Advances in Chemical Biology

Programme, 30 January 2018

Workshop, Tuesday, 30 January 2018

09.00

   -

12.00

Tutorial Workshop (seperate registration necessary)

Small molecule drug discovery - an introductory course with a glance at cancer immunotherapy

Kurt Ritter, Sanofi, D

Status Seminar, Tuesday, 30 January 2018

 

13.00

Keynote Lecture

Targeting Protein-Protein Interactions

Kristian Strømgaard, Copenhagen, DK

13.40

Encoded macrocyclic peptide libraries in drug discovery

Andreas Marzinzik, Basel, CH

14.00

Combining chemical biology approaches with mass spectrometry-based proteomics

Henrik Daub, Munich, D

14.20

MALDI mass spectrometry assays and - imaging for drug profiling and spatially resolved PK-PD studie

Carsten Hopf, Mannheim, D

14.40

Peptide antibiotics - structure, biosynthesis and mode of action

Roderich Süssmuth, Berlin, D

15.00

Towards nucleoside-derived antibiotics

Christian Ducho, Saarbrücken, D

15.20

COFFEE BREAK

 

15.50

Keynote Lecture

Tools for Deciphering the Information Layer beyond the Genome Sequence

Andreas Marx, Konstanz, D

 16.30

Chemical biology of protein phosphatases

Maja Köhn, Freiburg, D

 16.50

The power of chemoselectivity: Functional protein conjugates for proteomic and pharmacological research

Christian Hackenberger, Berlin, D 

 17.10

Peptoids as chemokine capture agents 

Katja Schmitz, Darmstadt, D

17.30

Poster Lectures

 

P21 Identification of inhibitors of the anti-infective target DXS using ligand-based virtual screening and X-ray crystallograhy

A. Hirsch, Helmholtz Institut für Pharmazeutische Forschung Saarland

 

P01 New Approaches for Enzyme Replacement Therapy of Lysosomal Storage Diseases by Mass Spectrometric Identification and Affinity Quantification of Antibody Epitopes

M. Przybylski, Steinbeis Transfer Zentrum

 

P02 Investigating the in situ formation of covalent reversible inhibitors of Enterovirus D68 3C protease

C. Tauber, Freie Universität Berlin

 

P06 Discovery of Irreversible FLT3-Inhibitors with Activity in Acute Myeloid Leukemia Cell lines by Virtual Screening

D. Bensinger, Technische Universität Darmstadt

P07 Novel extracellular-targeted Drug-Conjugates based on Ratjadone A

P. Klahn, TU Braunschweig

 

P17 Synthetic nucleosomes reveal interaction partners of phosphorylated and O-GlcNAcylated histone H2B Serine 36

S. Nadal, University of Oxford

18.00

RECEPTION AT THE POSTERS

18.45

DINNER

 

19.50

Evening Lecture

CETSA in preclinical and clinical research

Pär Nordlund, Stockholm, S

20.30

General assembly of the Joint Working Group Biology

 Programme, Wednesday, 31 January 2018

Become a member